Literature DB >> 32647984

Letter to the Editor: Safety and Efficacy of Bedside Peritoneal Dialysis Catheter Placement in the COVID-19 Era: Initial Experience at a New York City Hospital.

Venice Chávez Valencia1, Francisco Alejandro Lagunas Rangel2, Citlalli Orizaga de la Cruz3.   

Abstract

Entities:  

Year:  2020        PMID: 32647984      PMCID: PMC7346844          DOI: 10.1007/s00268-020-05677-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


× No keyword cloud information.
We read with interest the article by Vigiola-Cruz et al. [1] and we would like to offer the following comments. First, acute renal replacement therapy (RRT), when required for acute kidney injury (AKI), can be administered in three different forms: continuous RRT, intermittent RRT, intermittent hemodialysis or slow extended dialysis, and peritoneal dialysis (PD). Several studies have reported satisfactory performance and outcomes with PD [2]. In this context, dialysis in patients with COVID-19 and AKI was required up to 9% [3], where the indication to start renal replacement is managed according to international guidelines. In this pathology, renal replacement is very useful given the large number of factors that are aggressive to the kidney, where hemodialysis has been the main form of replacement therapy, but DP may be a safe alternative with catheter placement in the bedside of the patients. Second, COVID-19 has been isolated from different samples (blood, oropharyngeal swabs, urine, feces, etc.), but not from the peritoneal effluent. Wang W. et al. [4] showed in 1070 samples collected from 205 patients with COVID-19 that bronchoalveolar lavage fluid samples had higher positive rates (93%), followed by sputum (72%), nasal swabs (63%), fibrobronchoscope brush biopsy (46%), pharyngeal swabs (32%), feces (29%), and blood (1%). However, it is important to remember the viral loads detected in patients with hepatitis B and C, and the infectivity of the peritoneal effluent. Cusumano AM. et al. [5] reported that the hepatitis C virus (HCV) crosses the peritoneal membrane and can be detected in the dialysate of PD patients with proven viremia. Third, although it is true that the recommended personal protection equipment was used for the placement of the catheter, what is the potential risk of infectivity due to the viral load in the effluent?; what is the potential risk of infection in the medical staff?; what is the intra-abdominal pressure?; and, how do ventilatory parameters behave in patients with and without receiving pronation therapy and PD? The final point is that while this still seems unknown or under study, we need to ask ourselves and design new studies to answer these questions, given the great opportunity offered by peritoneal dialysis for those areas where hemodialysis is difficult to access due to both the economic problem and its availability.
  5 in total

Review 1.  Acute kidney injury.

Authors:  Claudio Ronco; Rinaldo Bellomo; John A Kellum
Journal:  Lancet       Date:  2019-11-23       Impact factor: 79.321

2.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens.

Authors:  Wenling Wang; Yanli Xu; Ruqin Gao; Roujian Lu; Kai Han; Guizhen Wu; Wenjie Tan
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

3.  Identification of hepatitis C virus RNA in peritoneal dialysis fluid of patients with viremia.

Authors:  Ana M Cusumano; Flavia Poratto; Noemí del Pino; José L Fernández; Antonio Vilches
Journal:  Perit Dial Int       Date:  2005 Sep-Oct       Impact factor: 1.756

4.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

5.  Safety and Efficacy of Bedside Peritoneal Dialysis Catheter Placement in the COVID-19 Era: Initial Experience at a New York City Hospital.

Authors:  Mariana Vigiola Cruz; Omar Bellorin; Vesh Srivatana; Cheguevara Afaneh
Journal:  World J Surg       Date:  2020-08       Impact factor: 3.352

  5 in total
  2 in total

Review 1.  Renal replacement therapy for critically ill patients with COVID-19-associated acute kidney injury: A review of current knowledge.

Authors:  Rasha Samir Shemies; Eman Nagy; Dalia Younis; Hussein Sheashaa
Journal:  Ther Apher Dial       Date:  2021-08-27       Impact factor: 2.195

Review 2.  Acute Kidney Injury in COVID-19 Patients: Pathogenesis, Clinical Characteristics, Therapy, and Mortality.

Authors:  Venice Chávez-Valencia; Citlalli Orizaga-de-la-Cruz; Francisco Alejandro Lagunas-Rangel
Journal:  Diseases       Date:  2022-08-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.